<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table6" position="float"><object-id pub-id-type="doi">10.7554/eLife.28020.012</object-id><label>Table 6.</label><caption><title>Antiviral activity of GRL-142 against viruses obtained after in vitro selection.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Virus before selection</th><th>Mean IC<sub>50</sub> in nM&#160;&#177;&#160;SD</th><th>Virus after selection</th><th>Mean IC<sub>50</sub> in nM&#160;&#177;&#160;SD</th><th valign="bottom">Fold-change</th></tr></thead><tbody><tr><td>cHIV<sub>NL4-3</sub><sup>WT</sup></td><td>0.019&#160;&#177;&#160;0.017</td><td>HIV<sub>NL4-3</sub><sup>142-WK36</sup>*</td><td>0.29&#160;&#177;&#160;0.06</td><td>15</td></tr><tr><td><sub>rCL</sub>HIV<sub>T48</sub></td><td>0.0052&#160;&#177;&#160;0.0017</td><td><sub>rCL</sub>HIV<sub>T48</sub><sup>142-WK36</sup>*</td><td>4.0&#160;&#177;&#160;0.5</td><td>769</td></tr></tbody></table><table-wrap-foot><fn><p>*Viruses were obtained at 36 week of the in vitro GRL-142 selection.</p><p>All assays were conducted in triplicate, and the data shown represent mean values (&#177;1 standard deviation) derived from the results of three independent experiments.</p></fn></table-wrap-foot></table-wrap>